Our program, already available to pet veterinarians since 2023,  will also be available to farm animal veterinarians worldwide during 2025. With Let's do it smart, we offer them concrete tools for choosing pest control solutions tailored to the real needs of each farm. This helps preserve the fragile balance between man, animal and ecosystem.

90% of cats over the age of 10  have joint issues¹ which can lead to mobility impairment and impact their quality of life. To keep their joints healthy and improve their mobility, our teams have developed a new Movoflex formula dedicated to cats. A novel soft chew, gradually available in Europe from September 2024.

This September, our American teams formed a strategic alliance with the association for pet obesity prevention (APOP) to confront the growing threat of pet obesity in the United States and raise awareness of the importance of pet nutrition.

For several decades, we have been providing industry professionals with solutions to improve milk production. From August 12-14, our teams will be at the National Mastitis Council to present our Smart DCT tool. Its purpose? To make it easier to implement selective dry-off in herds and improve milk quality worldwide.

The quality of dogs' and cats' skin and coat is essential for their health and their bond to humans. That’s probably why, since the 80’s, veterinary dermatology has grown to be the primary reason for consultations in pets. At Virbac, we have been part of this history from the outset, working alongside the founding fathers of modern veterinary dermatology, paving the way for innovation for the well-being of our companion animals. This July, as for every edition since the first one, we are principal sponsor of the 10th World Congress of Veterinary Dermatology. 

Small dogs suffer up to five times more oral disease¹ than other dogs. To nourish them while taking care of their oral health, our teams have reformulated our Veterinary HPM Small & Toy food. Launched in Europe in June, the new formula now includes a natural ingredient with proven efficacy against plaque, tartar, bleeding gums and bad breath.

In June, 10 European veterinary experts in canine mobility met in Nice to share with our teams their experience and knowledge on canine mobility disorders.

On April 17, our teams, in collaboration with recognized experts, organized a webinar dedicated to the first WSAVA guidelines on reproductive control for dogs and cats. More than 6,000 veterinarians from around the world expressed interest in this important animal health topic.

More than 3,500 veterinarians in South America registered for the webinar our teams organized last April. Our goal: to share the latest recommendations on canine vaccination from the World Small Animal Veterinary Association (WSAVA). 

For more than 20 years, our teams have worked to combat this zoonotic disease that threatens the health of dogs and humans alike. In 2024, we continue to work to bring diagnostic, prevention and treatment solutions to veterinarians and dog owners in endemic areas. Our latest stop is France, which will host the Animal Leishmaniosis International Veterinary Event in Nice in April.

As in other parts of the world, around 10%¹ of dogs in Asia suffer from atopic dermatitis. Since 2022, our teams have been stepping up their efforts to develop our global DailyDerma program in the region. The goal? To better help Asian veterinarians optimize their dermatology practices and improve the management of skin diseases, especially complex atopic dermatitis. 

One year after the launch of Suigen Rota Coli, our teams in France and Germany are now offering a second vaccine for swine, Suigen APP 2,9,11. This new vaccine complements our solutions for the prevention of major swine diseases, helping farmers to better control the health of their farms.

Our range of dermatological (AKI) and hygiene (Allerderm) shampoos has been redesigned to limit ecological impact and simplify use for pet owners. The new packaging is now made from recycled plastic, while the innovative formulations, which have been constantly improved over the last few decades, remain unchanged.

Available in five major Chinese cities since last October, our Veterinary HPM^® physiological foods are the only ones in the country to be distributed exclusively in veterinary clinics. This is a novel approach in the region, in line with our medical and scientific approach to animal nutrition. 

Because we are all part of the same ecosystem, parasite control is a necessity which must be carried out while preserving the delicate balance between the health of animals, humans and their environment. With “Let's do it smart”, we provide veterinarians with the tools they need to tailor the solution to the animal's specific needs, thus contributing to a more reasoned use of parasiticides. 

On October 11, 2023, the U.S. Food and drug administration (FDA) approved our solution for the treatment of Giardia duodenalis infections in dogs.

A study published in September 2023 has scientifically demonstrated that Vet Aquadent^® FR3SH^™ is an effective option to help maintain dogs' oral health after professional dental cleaning.

In France and around the world, the medicalization of cats continues to progress, helping to increase their life expectancy. Two major pathologies affect these aging cats: chronic kidney disease and osteoarthritis. Specially adapted nutrition can help. That's why we're launching VETERINARY HPM^® Kidney & Joint in Europe in September. This new nutrition program enables the combined and gradual management of chronic kidney disease and osteoarthritis, thus improving the animal's quality of life. 

Otitis externa is one of the main reasons why dogs visit the vet. Highly uncomfortable and painful for the animal, their treatment has until now involved the use of antibiotics in most of the cases. Starting this June, our teams are changing the way the disease is managed, by offering a Europe-wide antimicrobial-free solution, recommended as a first-line treatment in acute canine otitis externa where microbial overgrowth.

Atopic dermatitis is an inflammatory skin disease that affects 10% of dogs¹. Very disabling for the animal, it is also complex to diagnose and treat. To improve its management, our teams have developed DailyDerma: an innovative programme that brings together veterinarians and owners for better long-term management of the disease.

In 2015, our Veterinary HPM^® dog and cat foods made their first appearance in Europe; they are now present in more than 30 countries worldwide. In 2023, we are continuing their development in Asia: after Japan, they have been available in India since last March, providing veterinarians and owners in the country with a preventive nutrition solution that contributes to the health of domestic carnivores.

Heartworm disease is a potentially fatal pathology affecting mostly dogs. Endemic to the Mediterranean basin, it appeared in Eastern Europe about ten years ago. Since February 2023, our teams have been offering veterinarians and owners in this region of the world a new, easy-to-use annual preventive solution to protect their pets effectively¹. 

On February 21, our farm animals team organized a webinar attended by nearly 900 veterinarians from all over the world. The objective? To present our new Smart DCT tool, which allows a better assessment of the infectious pressure in dairy herds during the dry period. This action aims at supporting better adapted treatments and a more responsible use of antibiotics.

Rotavirus is one of the main agents causing diarrhea in piglets¹. Since December 2022, our teams have been providing industry professionals in France and Germany with the very first rotavirus vaccine registered for pigs, enabling the immunization of newborn piglets via their mother’s colostrum.

Mobility issues are common in dogs and can greatly impact their quality of life. To keep their joints healthy, our teams have developed MOVOFLEX^®, a new joint supplement combining five ingredients, including eggshell membrane. It includes an innovative formulation, gradually available in Europe from November 2022, for a complete action that significantly contributes to improving the animal's mobility.

Pet reproduction control habits vary from one country to another. In Latin America, 60 to 70% of male dogs are not castrated, often because dog owners are concerned about the surgery and its possible consequences. Alternative solutions exist and are available in a growing number of countries in this area. Danilo Martinez, our Latin America pet marketing manager at Virbac, tells us more.

We continue to increase our footprint in the livestock market and are proud to announce the launch of TENOTRYL^TM (enrofloxacin) injectable solution for use in cattle and swine. Our product was approved by the FDA on March 28th and will be available to those who care for animals beginning in July. TENOTRYL^TM (enrofloxacin) injectable solution comes in 100, 250 and 500 ml vials.

Although neutering of pets is sometimes essential, methods are evolving to meet new societal expectations. At Virbac, we offer the Suprelorin^® implant, a reversible medical neutering solution. Used since 2007 for male dogs, Suprelorin^® obtained on June 14, 2022, an extension of its marketing authorization in the European Union for use in male cats and prepubescent bitches. The extension of its application offers veterinarians new solutions to better adapt to the expectations of owners and the needs of their animals.

Oral health is essential to the overall health and quality of life of cats and dogs, and their owners have an active role to play in preventing dental disease. That is why we recently supported FECAVA's initiative: educational fact sheets to help veterinarians educate owners about the importance of their pets' oral health.

Limiting the use of treatments, in particular antibiotics, by supporting the body's natural processes: this is one of the objectives of micronutrition or trace mineral supplementation. On the occasion of our 30 years of expertise in this field, let's take a look at what has become one of the pillars of our approach to cattle health.

In June, join us at the IPVS World Congress in Brazil. We are sharing with swine professionals the latest scientific data on porcine circovirus as well as our preventive approach to swine health, which emphasizes vaccination tools and updated technology. 

On the occasion of the Chinese launch of our key anti-parasite products, Milpro^® and Effipro Duo^®, Virbac offers an innovative approach based on personalized protocol.

With a world population that could reach 9 billion people by 2030, we at Virbac anticipate the growing importance of aquaculture as an essential source of protein for humans in the years to come. We have been present for several years in all key segments of the sector, in warm and cold waters, and in 2022 we will continue our actions to help farmers to meet this growing demand in a sustainable way. Our global approach combines solutions focusing on prevention and services to implement them effectively.

In order to promote the urinary health of cats, our teams have developed two new wet foods. They will soon be available to cat owners throughout Europe, as an addition to our Veterinary HPM^® dry food range.

United States: Virbac enters the pet nutrition market with the launch of a product range for neutered and spayed dogs and cats.

Although neutering of pets is sometimes essential, methods are evolving to meet new societal expectations. At Virbac, we have been offering a reversible alternative to surgical castration for several years. In 2021, we are continuing our efforts to make this alternative available to more and more dog owners throughout the world and to support professionals in adopting this solution that is more respectful of the animal's physical integrity.

Since 2017, we have been offering European veterinarians Speed Reader^TM, an in-clinic analyzer for the determination of blood markers and a series of biomarker tests. This year, we are enriching our in-clinic diagnostic solutions with a software that allows all analyses to be collected on a single digital platform, for optimal monitoring of each animal.

Respiratory diseases are one of the most common pathologies affecting cattle and swine: all over the world, they are responsible for a high mortality rate in herds and significant economic losses. At Virbac, we support a reasonable use of antibiotics by using new technologies to help veterinarians and farmers make the right treatment decision at the right time and improve dosage and traceability.

On November 16, 2020 the Food and Drug Administration (FDA) granted approval of our new treatment against canine skin tumors. With this approval, we bring U.S. veterinarians a true innovation in canine oncology and a new option to manage mast cells tumors, the most common skin cancer diagnosed in dogs.

The longer life span of pets goes hand in hand with the increase in geriatric diseases, particularly the number of cancers being diagnosed. Since the beginning of 2020, we have been offering European veterinarians an innovative treatment solution that specifically targets mastocytomas, the most common form of canine skin cancer.

By 2 years of age, 70% of cats and 80% of dogs have some form of dental disease (Niemiec BA., 2008). Dental care prevention is key to avoid serious and painful disorders that can affect pets’ overall health and lifespan. Let's discover together in this video how we can improve our four-legged companions’ dental hygiene!

7.7 billion people on Earth, half live with pets. Every day, dogs and cats are exposed to unwanted parasites, vectors of various diseases that can affect their health and sometimes our own. We are all part of the same ecosystem. Protection against parasites is therefore a necessity that imposes to find the right balance between the health of animals, humans and their environment. That’s why our solutions allow veterinarians and owners to adapt protection to the specific parasite risk of each animal so that, all together, we can contribute to a responsible use of parasiticides.

In a growing number of countries, companion animals are considered to be sentient beings that are a part of the family. Although sterilization is sometimes necessary, the methods to manage dogs’ fertility and unwanted behaviours are changing to take societal expectations into consideration.

Neonatal gastroenteritis is the leading cause of calf mortality before the age of one month and causes significant losses to farmers. With our Calf Care Solutions program, we work with veterinarians and farmers to adopt a comprehensive calf health management approach that integrates diagnosis, prevention and care. Our goal is to share our tools and technical knowledge to more effectively manage on-farm diarrhea episodes through sustainable farming practices that respect animal welfare.

Through its partnership with QBiotics, Virbac is providing veterinarians in Europe with a breakthrough injectable solution to treat mastocytoma in dogs. With this new treatment, the Group once again demonstrates its commitment and ability to offer innovative solutions for the advancement of veterinary science.

Behavior disorders and joint problems are common in dogs and can affect their quality of life and their relationship with humans. With multifunctional chews, pet owners now have an easy to give solution to support their pet’s overall health and wellness, while acting on their dental hygiene.

Today 25 to 40% of dogs are overweight or obese. This is true everywhere in the world, whatever the size or breed. Since obesity can have serious health consequences, Virbac offers, in partnership with an expert in dog activity, PitPat, a comprehensive program combining a healthy diet and the measurement of the dog's activity using a device placed on its collar. Find out more about this approach that helps improve the relationship between the owner and his pet by watching the video below.

Today, farmers have to ensure optimal farming conditions both for the animal welfare and productivity. Yet, in the lifetime of an animal or during the production cycle, there are periods where induced oxidative stress is particularly intense. In such cases, farmers have to supplement animals with trace mineral elements. To learn more about micro-nutrition, click below to watch the video.

A major concern for pet owners, bad breath can disrupt the close bond between pet and owner and signal deeper health issues. In 2019, for the first time ever in China, Virbac introduced dental care solutions that include FR3SH™ technology to target the oral and digestive causes of bad breath.

In Turkey, the prevalence of canine leishmaniosis can reach 25% in some regions, especially around the Mediterranean basin. To face this zoonosis that is currently under-diagnosed by veterinarians and misunderstood among Turkish owners, Virbac has made available, since March 2019, CANILEISH^®, the first veterinary vaccine to prevent this disease.

Mid-March, Virbac was rewarded in the United Kingdom for its digital Veterinary HPM^™ campaign by the VMA (Veterinary marketing association), which annually celebrates the best marketing initiatives in the field of animal health.

At the end of 2018, Virbac launched an online campaign in North America encouraging owners to consult their veterinarian about their dog’s dental health. It included a humorous video broadcasted on social networks, featuring a rubber toy that hates being chewed by a dog with bad breath.

In August, the FDA approved the transfer of production to the Virbac St. Louis site (Missouri) of a parasiticide for dogs acquired by the company at the beginning of 2015. The complexity of the industrial extrusion process required all the skills and attention of the American subsidiary and the Group's Production/Quality teams for nearly three years.

Bad breath is a common complaint of dogs’ owners but it can also be a sign of periodontal or digestive issues that can be painful for the pet. Thanks to a new formula, the C.E.T^® VEGGIEDENT^® FR3SH^™ dental chews tackle the oral causes of bad breath and help to restore the animal's intestinal balance while freshening its breath. Available since 2018 in the United States, Canada, the United Kingdom, France, Spain and Japan, they will gradually be present around the world in 2019.

One of the present challenges of swine producers is finding solutions that preserve farm productivity while reducing the use of antibiotics. In Europe, Latin America and Asia, Virbac is assisting veterinarians and farmers with technical solutions and on farm training that focus on prevention and are based on a good reproduction management.

Since 2017, Virbac has been offering veterinarians Speed Reader^TM, a blood marker dosage analyzer with a series of biomarker tests. Usable directly in-clinic, these newest additions to the diagnostic range facilitate screening of common diseases in cats and dogs and ensure better monitoring of the animal.

Maintaining good health and welfare of cows is central to Virbac's approach of dairy production. Virbac created a specific program for professionals of dairy farming called Target 150. This program aims at bringing global & integrated solutions and protocols for a better and more sustainable production of milk. Developed in close cooperation with worldwide known experts, Target 150 ™ encourages prevention and answers the main problematics of the 150 critical days of production cycle of the dairy cows. As an essential part of the program, the second Virbac Dairy Symposium was organized in September 2017 to contribute strengthening the skills of dairy farming professionals and prepare them to the emerging technologies of tomorrow.

Two years after its launch, with a rating of 17.5/20, the VETERINARY HPM^® Adult with salmon neutered & entire cat is one of the ‘best choices’ amongst thirteen dry cat foods (kibbles) tested by the INC (Institut National de la Consommation [French National Institute for Consumer Affairs]). This rating makes up for several years of development.

The treatment of dogs infected with leishmaniosis has been authorized in Brazil since 2016. Thanks to its publicity campaigns and its treatment solution introduced in January 2017, Virbac is contributing to the fight against this disease which, on a world scale, touches about 1 million of humans. 

VETERINARY HPM™ dietetic is a new generation of nutrition for cats and dogs with health problems, created by staying close to the nutritional requirements of carnivores, respecting the nutritional requirements of carnivores. These foods should be recommended by the veterinarian depending on the animal's health problem. A veterinarian's option should be sought before use. Available since spring 2017 in European veterinary clinics, the VETERINARY HPM™ dietetic range will also be launched in Latin America (Mexico, Costa Rica and Chile) by the end of the year.

Whether in the meat or dairy industries, quality production requires animals that are healthy from birth onward! With this in mind, Virbac has been progressively rolling out a complete Calf health management program in Europe since 2016. 

In May 2016, European practitioners (France, UK and Austria) discovered Effipro^® Duo, a new parasiticide used to treat and prevent tick and flea infestations in dogs and cats. The advantages of this product described by the Global Marketing manager parasiticides.

Following the launch of the VETERINARY HPM™ physiological range in 2015, Virbac started from March 1^st the launch of VETERINARY HPM™ dietetic for dogs and cats in Europe. A complete range still close to the nutritional requirements of carnivores and associated to the "Veterinary global care", a new global nutritional approach.

The product VETERINARY HPM^® Adult Small & Toy has received a rating of 16.4/20 from the independent French consumer association UFC-Que Choisir. The cited product has been qualified as one of the “best choices” amongst the twenty complete dog foods that were tested. 

Since 2012, Virbac has maintained a presence in China through a commercial subsidiary that now has about thirty collaborators. How is the subsidiary adapting to this ever-changing market? Answers by the subsidiary general manager.

On March 8, 2016, Virbac US announced the launch of the latest advancement in canine joint health supplementation, MOVOFLEX™ Soft Chews. Formulated with a unique and proprietary blend of ingredients, MOVOFLEX™ Soft Chews provide comprehensive canine joint support in a once-a-day palatable soft chew.

On March 1, 2016, Virbac US announced the launch of the C.E.T.^® OraStrip^® Dental Diagnostic Test (currently distributed in the USA), the first and only test in the animal health market that detects periodontal infection in dogs, providing visual test results to support veterinarians’ dental treatment recommendations and enhance client compliance.

Virbac has been distributing the parasiticide medicines Activyl^® and Activyl^® Tick Plus in Europe since January 1, 2016. The integration of these two medicines in the parasiticide product portfolio fulfils Virbac’s wish to offer complementary solutions to veterinarians.

Virbac commercializes a new hyper premium nutritional concept for dogs and cats! 

26%. This is 2014 Virbac Colombia's market share on the dog and cat vaccines segment. This figure is evidence of the success that the subsidiary has met with in this fast-growing sector. The story of a lightningfast journey by colombian Marketing manager.

New premises, dairy crisis, market concentration... 2015 is marking a turning point for the subsidiary in New Zealand. How are such evolutions to be tackled? Answers from general manager of the subsidiary.

November 2014, London. For its use of augmented reality technology Virbac UK is awarded the Best Large Stand award for the most innovative stand. Just a gadget or a genuine opportunity for improved communication? Some answers from the companion animal business unit director of the subsidiary.

April 2014, Moscow. At Russia's largest veterinary congress, Virbac launched Cortavance, a corticoid for the treatment of inflammatory dermatosis in dogs. A major step forward for the companion animal portfolio in this country. Explanations by the Rest of Europe product manager.

After Multimin in 2011, Virbac RSA finalized in 2012 the acquisition of the worldwide rights to Browse Plus, a nutritional supplement for food producing animals and leader on the South African market since 1994. This acquisition by Dayle Sinclair, product manager.

In 2014, the innovative Flexibag^® and Farmpack^® products from Virbac were awarded three prizes: the 'Janus de la Santé' award for an environmentally-friendly design, the Pharmapack award and a "Sommet d’Or" award. In Flexibag^® and Farmpack^®, Virbac offer the first truly successful ergonomic design for simplified anti-parasite treatment of cattle and sheep, one which also improves productivity in the stock-rearing sector.

France, Germany, Switzerland, Portugal, Austria, United Kingdom and Scandinavia. These were the first European countries to launch Pronefra in the first half of 2014. A presentation of this food supplement by the global marketing manager supportive care & topical hygiene.

Viva VIVID! summer 2013, Virbac Australia opened a new R&D centre in Penrith surrounded by those involved in the local animal health industry. A key event for the development of the subsidiary’s biological activity in food producing animals. Explanations by Robert Dempster, the local RDL manager.

May 2013, Prague. In partnership with the European Veterinary Dental Society, Virbac is launching the e.VDS, an application for evaluating animal dentition (scoring) and developing knowledge for veterinarians all over the world. A look at the tool’s functionalities and objectives with Alain Mondon, Global Marketing manager, companion animals parasiticides.

In summer 2012, Virbac Brazil launched Effipro, a fipronil-based external parasiticide for dogs and cats. After a year of marketing, sales are good. A look at this success with Daniela Baccarin, product manager.

The successful management of an outbreak of neonatal calf diarrhoea relies on the individual treatment of sick animals and the prevention of disease transmission. In this context, identification of the pathogens involved enables the vet to select the most appropriate treatment and prophylactic measures for each case.

Faithful to its strategy of continuous innovation, this year Virbac is launching the 1st mini polymeric transponder in Europe (France, Netherlands, Germany, Austria, Belgium), the BackHome^® Biotec Slim Transponder.

Rilexine and Suprelorin F: two products launched in the American market mid 2012 thanks to the hard work of the Virbac US R&D teams to adapt the registration dossiers. A look at the challenges with Craig Parks, R&D vice-president.

Since June 2012, Virbac France has offered a long-term treatment that aims to reduce inflammation and pain for dogs with acute and chronic musculoskeletal disorders. This medicine adds to Virbac's canine osteoarthritis range which now provides comprehensive care for canine osteoarthritis.

01/02/2010. Paris - France. Pharmapack award "Home risks prevention - veterinary category" has been awarded to Milteforan, the first veterinary medicinal product intended to treat the leishmaniasis and that can be administered by oral route. 

The fruit of several years of development, Effipro^® Spot On and Effipro^® Spray are two Fipronil-based medicines which treat flea and tick infestations in dogs and cats.